K.L.E.S Dr. Prabhakar Kore Hospital & Medical research Centre Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2012
NCT01726413
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

KLES, Dr Prabhakar Kore Hospital and Medical Centre, Nehru Nagar, Belagavi- 590010, Belgaum, Karnataka, India

Active Ingredients

Drugs in Phase 3 Trials (3)

ceftriaxone (rocephin) (1 trial)

meropenem (merrem) (1 trial)

sulbactam (unasyn) (1 trial)

Drugs in Phase 2 Trials (1)

grc 17356 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Diabetic Neuropathies (Phase 2)

Infections (Phase 3)

Pain (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Pyelonephritis (Phase 3)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4